EU Clinical Trial Information System (CTIS)

Explanation of how the number of participants for analysis was determined. Includes whether analysis was per protocol, intention to treat, or another method. Also provides relevant details such as imputation technique, as appropriate.

I searched for some studies on AstraZeneca Clinical Trials, and found these studies that may also be of interest to you.
Here is the link to my search results

Official Title

The purpose of this study is to compare the changes in a proliferation biomarker in subjects receiving Anastrozole or Anastrozole/ZD1839 combination.

Phase II Neoadjuvant ER+/PgR + Arimidex +/- Iressa study

Research Site

Phase II, placebo controlled, parallel group, double blind, randomised, multicentre trial comparing the Anastrozole (Arimidex®) placebo combination to the Anastrozole - ZD1839 (Iressa™) combination as neoadjuvant treatment in postmenopausal women with stage I-IIIB breast cancer and Oestrogen Receptor (ER) and/or Progesterone (PgR) positive tumours

Phase II Neoadjuvant ER+/PgR + Arimidex +/- Iressa study

Official Title

Medical condition

Phase

Healthy volunteers

Study drug

Sex

Actual Enrollment

Study type

Age

Date

Study design

Verification:

Sponsors

Collaborators

Inclusion Criteria

Exclusion Criteria

Research Site

Research Site

Research Site

Research Site

Research Site

Research Site

Research Site

Research Site

Documents available

Trial Results Summaries

Contacts

Contact

Investigators

Principal Investigator